Newsroom
Latest News
WASHINGTON, D.C.— The co-chairs of the Congressional Pro-Choice Caucus, U.S. Reps.
Reps. Diana DeGette (D-Colo.) and Fred Upton (R-Mich.) introduced the Cures 2.0 Act (H.R. 6000) on Nov. 15, a bill aimed at accelerating medical research and patient access to novel therapeutics.
WASHINGTON, D.C. – The U.S. House of Representatives today approved a once-in-a-generation spending bill that seeks to make health care, child care, housing and education more affordable for millions of hardworking families, and take on the global climate crisis.
WASHINGTON, D.C. – The co-chairs of the Congressional Diabetes Caucus, U.S. Reps.
WASHINGTON, D.C. –U.S. Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) today introduced their highly anticipated, bipartisan Cures 2.0 legislation that some leading health care organizations are calling a potential "game changer" in how the U.S. conducts biomedical research going forward.
WASHINGTON, D.C. – The U.S.
Rep. Diana DeGette (D-Colo.), the chair of the Congressional Diabetes Caucus, pressed Congress to fully fund a new public-private health agency to tackle some of the country’s most intractable diseases.
WASHINGTON, D.C. – The U.S. House of Representatives today voted to advance legislation – led by U.S. Reps. Diana DeGette (D-CO) and Elissa Slotkin (D-MI) – to improve the nation's Strategic National Stockpile to ensure it's ready to respond to future public health emergencies.
WASHINGTON, D.C. - Tomorrow, a key congressional oversight panel will hold a hearing to determine what needs to be done to revitalize the U.S. Chemical Safety Board.
The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, chaired by U.S. Rep. Diana DeGette (D-CO), will hold a hybrid hearing that includes both in-person and remote attendance on Wednesday, September 29, 2021, at 10:30 a.m ET. This hearing will take place in the John D.